Literature DB >> 4088434

Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients.

M I Hunter, B C Nlemadim, D L Davidson.   

Abstract

Lipid peroxidation (LPx) products were measured as thiobarbituric acid-reactive substances (TS) and lipid-soluble fluorescent pigments (FP) in both plasma and CSF from MS patients and controls. Although no significant changes were found in MS plasma, we report here for the first time increases in both TS and FP in MS CSF (p less than 0.05 and p less than 0.01, respectively, compared with patients with other neurological diseases), indicating that increased LPx in CNS may be a feature of MS. Levels of transferrin were normal but caeruloplasmin (CP), a major antioxidant plasma protein, was significantly raised in MS patients (p less than 0.01) and this may represent an adaptive response to increased oxidative challenge. Neither of these proteins was detectable in CSF using radial immunodiffusion. There was no significant correlation between the severity or duration of the disease nor the period since the last relapse and either LPx products or CP suggesting that the changes observed in this work are not simply the direct result of demyelination and tissue damage.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4088434     DOI: 10.1007/BF00988606

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  34 in total

1.  Further studies on platelet adhesiveness and serum cholesteryl linoleate levels in multiple sclerosis.

Authors:  H Sanders; R H Thompson; H P Wright; K J Zilkha
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-08       Impact factor: 10.154

2.  The autoxidation of human red cell lipids induced by hydrogen peroxide.

Authors:  J Stocks; T L Dormandy
Journal:  Br J Haematol       Date:  1971-01       Impact factor: 6.998

Review 3.  Free-radical mechanisms in tissue injury.

Authors:  T F Slater
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

4.  Superoxide dismutase, reduced glutathione and TBA-reactive products in erythrocytes of patients with multiple sclerosis.

Authors:  G Polidoro; C Di Ilio; A Arduini; G La Rovere; G Federici
Journal:  Int J Biochem       Date:  1984

5.  Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis.

Authors:  S Gul; A D Smith; R H Thompson; H P Wright; K J Zilkha
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-08       Impact factor: 10.154

6.  Red blood cell glutathione peroxidase activity in multiple sclerosis.

Authors:  B Zachara; J Gromadzińska; J Czernicki; Z Maciejek; H Chmielewski
Journal:  Klin Wochenschr       Date:  1984-02-15

7.  The inhibition of lipid autoxidation by human caeruloplasmin.

Authors:  D J Al-Timimi; T L Dormandy
Journal:  Biochem J       Date:  1977-11-15       Impact factor: 3.857

8.  Essential fatty acids in the serum and cerebrospinal fluid of multiple sclerosis patients.

Authors:  I S Neu
Journal:  Acta Neurol Scand       Date:  1983-03       Impact factor: 3.209

9.  Leucocyte glutathione peroxidase activity and selenium level in multiple sclerosis.

Authors:  G E Jensen; G Gissel-Nielsen; J Clausen
Journal:  J Neurol Sci       Date:  1980-10       Impact factor: 3.181

10.  Erythrocyte glutathione perioxidase deficiency in multiple sclerosis.

Authors:  V K Shukla; G E Jensen; J Clausen
Journal:  Acta Neurol Scand       Date:  1977-12       Impact factor: 3.209

View more
  32 in total

1.  Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord.

Authors:  Tong Liu; K Christian Donahue; Jun Hu; Michael P Kurnellas; Jennifer E Grant; Hong Li; Stella Elkabes
Journal:  J Proteome Res       Date:  2007-06-16       Impact factor: 4.466

2.  A preliminary study about the effects of warm priming solution on oxidative stress and postoperative atrial fibrillation in open heart surgery.

Authors:  Mustafa Buyukates; Serefden Acikgoz; Erol Aktunc; Ozer Kandemir; Sait Mesut Dogan; Mustafa Aydin
Journal:  Wien Klin Wochenschr       Date:  2012-08-10       Impact factor: 1.704

Review 3.  Antioxidants in multiple sclerosis: do they have a role in therapy?

Authors:  Noel G Carlson; John W Rose
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic.

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Slobodan Vojinovic; Dragan Stojanov; Svetlana Stojanovic; Gordana Kocic; Dejan Savic; Tatjana Cvetkovic; Dusica Pavlovic
Journal:  Cell Mol Neurobiol       Date:  2013-05-16       Impact factor: 5.046

5.  Conjugated Linoleic Acid-Curcumin Attenuates Cognitive Deficits and Oxidative Stress Parameters in the Ethidium Bromide-Induced Model of Demyelination.

Authors:  Behnaz Barzegarzadeh; Homeira Hatami; Gholamreza Dehghan; Nazli Khajehnasiri; Mehdi Khoobi; Reihaneh Sadeghian
Journal:  Neurotox Res       Date:  2021-03-13       Impact factor: 3.911

Review 6.  The influence of nutritional factors on the prognosis of multiple sclerosis.

Authors:  Gloria von Geldern; Ellen M Mowry
Journal:  Nat Rev Neurol       Date:  2012-10-02       Impact factor: 42.937

7.  Is it possible to prevent contrast-induced nephropathy with dexpanthenol?

Authors:  Osman Sutcuoglu; Mehmet Kursat Derici; Ozge Tugce Pasaoglu; Burak Dumludag; Ozant Helvacı; Betul Ogut; Ipek Isık Gonul; Ulver Derici
Journal:  Int Urol Nephrol       Date:  2019-06-11       Impact factor: 2.370

Review 8.  Gemfibrozil, stretching arms beyond lipid lowering.

Authors:  Avik Roy; Kalipada Pahan
Journal:  Immunopharmacol Immunotoxicol       Date:  2009       Impact factor: 2.730

Review 9.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

10.  Simvastatin improves wound strength after intestinal anastomosis in the rat.

Authors:  G Karadeniz Cakmak; O Irkorucu; B H Ucan; A U Emre; B Bahadir; C Demirtas; O Tascilar; K Karakaya; S Acikgoz; G Kertis; H Ankarali; H Pasaoglu; M Comert
Journal:  J Gastrointest Surg       Date:  2009-07-04       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.